News 15 mai 2024 Allegria Therapeutics raises 3.5 million dollars in seed financing round Allegria Therapeutics has received seed funding of 3.5 million dollars from the founding investor Forty51 Ventures. The biotech startup is develo...
Aktuell 15 mai 2024 Allegria Therapeutics nimmt 3,5 Millionen Dollar in Seed-Runde ein Allegria Therapeutics hat eine Seed-Finanzierung von 3,5 Millionen Dollar durch den Gründungsinvestor Forty51 Ventures erhalten. Das Biotech-Star...
News 22 mai 2024 CUTISS secures 25 million Swiss francs from investors CUTISS has closed a first Series C financing round in the amount of 25 million Swiss francs. With this, the life sciences company with a focus on...
Unternehmerreisen High Performance Engineering Mission in Silverstone & MIA CTS24 Motorsport Engineering and Technology Show 14 out 2024–17 out 2024 Silverstone Reino Unido
Fact-Finding Mission High Performance Engineering Mission to Silverstone & MIA CTS24 Motorsport Engineering and Technology Show 14 out 2024–17 out 2024 Silverstone Reino Unido
Voyages pour PME High Performance Engineering Mission to Silverstone & MIA CTS24 Motorsport Engineering and Technology Show 14 out 2024–17 out 2024 Silverstone Reino Unido
News 01 mar 2024 Idorsia enters collaboration with Viatris The biotech company Idorsia from the canton of Basel-Landschaft and the North American pharmaceutical company Viatris are collaborating on the de...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
News 08 mai 2024 Swiss companies equip EarthCARE satellite Technologies developed by Beyond Gravity (formerly RUAG Space), Thales Alenia Space Switzerland and APCO Technologies are being installed in the ...
Unternehmerreisen Fact-Finding Mission to Chongqing, Dalian/Liaoyang & Beijing 24 jun 2024–28 jun 2024 China
Aktuell 01 mar 2024 Idorsia vereinbart Kooperation mit Viatris Das Biotech-Unternehmen Idorsia und der nordamerikanische Pharmakonzern Viatris arbeiten bei der Entwicklung zweier Phase 3-Medikamente von Ido...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
Actualités 19 out 2023 Nouveaux fonds pour le traitement de régénération tissulaire de Mimix Biotherapeutics La société biennoise Mimix Biotherapeutics a annoncé la clôture d’un important tour d’investissement, auquel ont participé des investisseurs euro...